Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies

被引:17
作者
Monzavi-Karbassi, B
Cunto-Amesty, G
Luo, P
Lees, A
Kieber-Emmons, T
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Biosynexus, Rockville, MD 20850 USA
关键词
peptide mimeotope; carbohydrate; antibody response; T-cell response; DNA immunization;
D O I
10.1006/biol.2001.0307
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Targeting antigens which cannot be readily addressed by genetic vectors is a major challenge in vaccine design. The inter-conversion of carbohydrate antigens into peptide mimetic forms provides a means to broaden the immune response to carbohydrate antigens. Peptides that mimic carbohydrate antigens offer new possibilities to augment immune responses to such antigens that include inducing carbohydrate reactive T-cell responses. Peptide mimeotopes can be formulated in a variety of ways that include multiple antigen peptides (MAP) and as DNA vaccines that prime for different antibody isotypes. On the immunological side we observe that: (i) depending on the immunogen formulation peptide mimetics can be processed by either CD5+ or CD5- B cells; (ii) peptide mimeotope immunization can induce cross-reactive responses to multiple carbohydrate forms; (iii) priming with peptide mimeotopes can enhance carbohydrate immune responses upon boosting and (iv) immunization with peptide mimeotopes can induce carbohydrate reactive T cells. (C) 2001 The International Association for Biologicals.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 36 条
[11]  
GalliStampino L, 1997, CANCER RES, V57, P3214
[12]   Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity [J].
Glithero, A ;
Tormo, J ;
Haurum, JS ;
Arsequell, G ;
Valencia, G ;
Edwards, J ;
Springer, S ;
Townsend, A ;
Pao, YL ;
Wormald, M ;
Dwek, RA ;
Jones, EY ;
Elliott, T .
IMMUNITY, 1999, 10 (01) :63-74
[13]  
Grant SC, 1999, CLIN CANCER RES, V5, P1319
[14]   BROADLY NEUTRALIZING ANTIBODIES TARGETED TO MUCIN-TYPE CARBOHYDRATE EPITOPES OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
HANSEN, JES ;
NIELSEN, C ;
ARENDRUP, M ;
OLOFSSON, S ;
MATHIESEN, L ;
NIELSEN, JO ;
CLAUSEN, H .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6461-6467
[15]   CROSS-RECOGNITION BY T-CELLS OF AN EPITOPE SHARED BY 2 UNRELATED MYCOBACTERIAL ANTIGENS [J].
HARRIS, DP ;
VORDERMEIER, HM ;
SINGH, M ;
MORENO, C ;
JURCEVIC, S ;
IVANYI, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3173-3179
[16]   Peptide anchor residue glycosylation: Effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition [J].
Haurum, JS ;
Tan, L ;
Arsequell, G ;
Frodsham, P ;
Lellouch, AC ;
Moss, PAH ;
Dwek, RA ;
McMichael, AJ ;
Elliott, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3270-3276
[17]  
Hiemstra HS, 1999, EUR J IMMUNOL, V29, P2385, DOI 10.1002/(SICI)1521-4141(199908)29:08<2385::AID-IMMU2385>3.3.CO
[18]  
2-2
[19]  
Jensen T, 1997, J IMMUNOL, V158, P3769
[20]   Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model [J].
Jones, RC ;
Kelley, M ;
Gupta, RK ;
Nizze, JA ;
Yee, R ;
Leopoldo, Z ;
Qi, K ;
Stern, S ;
Morton, DL .
ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (05) :437-445